This market research report segments the global blood screening market by technology (NAAT and multiplexed real-time PCR), by product (assays/consumables, instruments, and services), and by geography (APAC, EMEA, and the Americas). Key vendors analyzed in this market study are Abbott Diagnostics, bioMérieux, Grifols, and Roche Diagnostics.
Technavio’s market research analysts estimate the global blood screening market to grow at a CAGR of around 10% between 2015 and 2019. Rising incidences of various blood-borne infections has resulted in the development of advanced automated blood collection systems and high-throughput blood screening devices. The Americas dominates the global market for blood screening, occupying around 42% of the total market share. Growing awareness pertaining to blood safety and transfusion-transmitted infections is expected to augment market growth in this region.
The new market research report from Technavio provides a breakdown and analysis of the blood screening segments by technology.
“Vendors are increasingly adopting nucleic acid amplification technology (NAAT) for efficient and accurate blood screening. This is a highly sensitive and specific technique, and amplifies targeted regions of the viral DNA or RNA. NAAT provides additional blood safety by lowering the threats of transfusion-transmitted infections in blood recipients. Currently, the most popular NAAT techniques are the multiplexed PCR technology by Roche Diagnostics and transcription-mediated amplification-based NAAT by Grifols,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.
The blood screening market is undergoing a lot of technological advancements in terms of the tools and software usage. The electronic record systems facilitate medical experts to gain easy access to blood samples and study their genotypic and phenotypic information. The barcoding system and robust encryption algorithm help in the rapid identification and increase the safety of blood samples.
The key vendors in the global blood screening market are Abbott Diagnostics, bioMérieux, Grifols, and Roche Diagnostics. Competition between vendors in the developed countries is intense due to the availability of advanced blood screening assays and instruments. As many vendors compete with each other to gain superiority in this market, the launch of multiplexed assays by some prominent vendors will help them to gain traction in this market during the forecast period.
A more detailed analysis is available in the Technavio report, Blood Screening Market – Global Market Research 2015-2019.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
